BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260616T113000
DTEND;TZID=America/New_York:20260616T160000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Pathways to Exit: Market Authorization vs. Market Adoption in Medtech
DESCRIPTION:Many MedTech startups focus on "getting the green light" and stop short of what investors and strategics actually care about: durable market adoption and exit-ready value creation. Our panel of industry professionals will discuss how CEOs and founders can navigate the strategic tradeoffs between market authorization and market adoption\, and why aligning these decisions early is critical to building an asset buyers want to acquire\, not just what product regulators allow you to sell. Join CLA\, Avio\, BayCath Medical\, and Mobius Medical as we examine practical exit strategies in MedTech\, highlighting how integrated regulatory\, clinical\, commercial\, and financial decisions rather than isolated milestones can enhance company value. Who should attend Medtech leaders who want to think beyond clearance and structure their companies for adoption\, revenue\, and transaction readiness Medtech ecosystem partners who want to learn leading practices to support industry growth and success Schedule 11:30 a.m. Registration and networking\n11:45 a.m. Lunch\nNoon 1 p.m. Lunch and panel discussion\n1 p.m. Networking\n2 4 p.m. Optional Office Hours\n4 p.m. Event conclusion\nRegister Now
X-ALT-DESC;FMTTYPE=text/html:Many MedTech startups focus on &ldquo\;getting the green light&rdquo\; and stop short of what investors and strategics actually care about: durable market adoption and exit-ready value creation. Our panel of industry professionals will discuss how CEOs and founders can navigate the strategic tradeoffs between market authorization and market adoption\, and why aligning these decisions early is critical to building an asset buyers want to acquire\, not just what product regulators allow you to sell. \;
Join CLA\, Avio\, BayCath Medical\, and Mobius Medical as we examine practical exit strategies in MedTech\, highlighting how integrated regulatory\, clinical\, commercial\, and financial decisions &mdash\; rather than isolated milestones &mdash\; can enhance company value. \;
Who should attend \;
- Medtech leaders who want to think beyond clearance and structure their companies for adoption\, revenue\, and transaction readiness \;
- Medtech ecosystem partners who want to learn leading practices to support industry growth and success \;
Schedule \;
11:30 a.m. &mdash\; Registration and networking
11:45 a.m. &mdash\; Lunch
Noon &ndash\; 1 p.m. &mdash\; Lunch and panel discussion
1 p.m. &mdash\; Networking
2 &ndash\; 4 p.m. &mdash\; Optional Office Hours
4 p.m. &mdash\; Event conclusion
Register Now
LOCATION:2450 Holcombe Boulevard\, Suite 1420 Houston TX 77021
UID:e.1244.1471151
SEQUENCE:3
DTSTAMP:20260527T144516Z
URL:https://massmedic.growthzoneapp.com/events/Details/pathways-to-exit-market-authorization-vs-market-adoption-in-medtech-1742534?sourceTypeId=Hub
END:VEVENT
END:VCALENDAR